Skip to main content

2023 Investor Day: Diasorin 3.0

On December 15, 2023 Diasorin Management Team presented the new Business Plan confirming and broadening the strategic trajectories that will drive the evolution of the Group in the coming years.

Here you will find all the relevant materials, both for the full event and for the individual interventions.

Full Event

test

15/12/2023

Presentation

(4.97 MB)

15/12/2023

Press release

(294.02 KB)

15/12/2023

Transcript

(313.52 KB)

Welcome

test

Investor Day Kickoff

Michele Denegri, Chairman

Transcript

(124.14 KB)

Strategy

Investors Day - Strategic Settings

Strategic settings

Carlo Rosa, CEO

Presentation

(791.91 KB)

Transcript

(131.25 KB)

Immunodiagnostics

Chen Even, CCO

Presentation

(1.07 MB)

Transcript

(131.67 KB)

Molecular Diagnostics

Angelo Rago, President of Luminex

Presentation

(845.37 KB)

Transcript

(130.98 KB)

Licensed Technologies

Angelo Rago, President of Luminex

Presentation

(1.48 MB)

Transcript

(130.35 KB)

Focus on

Focus on the U.S.

Focus on the U.S.

Dustin Stewart, Vice President Commercial Operations N.A.

Presentation

(654.98 KB)

Transcript

(128.22 KB)

Sustainability

Eugenia Ragazzo, Investor Relations & ESG Analyst

Presentation

(1.18 MB)

Transcript

(9.83 KB)

Financials & Key takeaway messages

Financials

Piergiorgio Pedron, CFO

Presentation

(693.65 KB)

Transcript

(138.12 KB)
Investor Day - Key takeaway

Key takeaway messages

Carlo Rosa, CEO

Presentation

(398.47 KB)

Transcript

(7.02 KB)
investors Day - Q&A

Q&A

Transcript

(171.05 KB)

Keep in touch

Riccardo Fava, get in touch

Riccardo
Fava

Corporate Vice President Communication, ESG 
& Investor Relations

Diasorin S.p.A.
riccardo.fava@diasorin.it

Eugenia Ragazzo

Eugenia Ragazzo

Corporate Investor Relations & ESG Analyst
Diasorin S.p.A.
eugenia.ragazzo@diasorin.it